High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism

Federico Biscetti, Giuseppe Straface, Raimondo De Cristofaro, Stefano Lancellotti, Paola Rizzo, Vincenzo Arena, Egidio Stigliano, Giovanni Pecorini, Kensuke Egashira, Giulia De Angelis, Giovanni Ghirlanda, Andrea Flex

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

OBJECTIVE - High-mobility group box-1 (HMGB1) protein is a nuclear DNA-binding protein released from necrotic cells, inducing inflammatory responses and promoting tissue repair and angiogenesis. Diabetic human and mouse tissues contain lower levels of HMGB1 than their normoglycemic counterparts. Deficient angiogenesis after ischemia contributes to worse outcomes of peripheral arterial disease in patients with diabetes. To test the hypothesis that HMGB1 enhances ischemia-induced angiogenesis in diabetes, we administered HMGB1 protein in a mouse hind limb ischemia model using diabetic mice. RESEARCH DESIGN AND METHODS - After the induction of diabetes by streptozotocin, we studied ischemia-induced neovascularization in the ischemic hind limb of normoglycemic, diabetic, and HMGB1-treated diabetic mice. RESULTS - We found that the perfusion recovery was significantly attenuated in diabetic mice compared with normoglycemic control mice. Interestingly, HMGB1 protein expression was lower in the ischemic tissue of diabetic mice than in normoglycemic mice. Furthermore, we observed that HMGB1 administration restored the blood flow recovery and capillary density in the ischemic muscle of diabetic mice, that this process was associated with the increased expression of vascular endothelial growth factor (VEGF), and that HMGB1-induced angiogenesis was significantly reduced by inhibiting VEGF activity. CONCLUSIONS - The results of this study show that endogenous HMGB1 is crucial for ischemia-induced angiogenesis in diabetic mice and that HMGB1 protein administration enhances collateral blood flow in the ischemic hind limbs of diabetic mice through a VEGF-dependent mechanism.

Original languageEnglish
Pages (from-to)1496-1505
Number of pages10
JournalDiabetes
Volume59
Issue number6
DOIs
Publication statusPublished - Jun 1 2010

Fingerprint

HMGB1 Protein
Vascular Endothelial Growth Factor A
Ischemia
Extremities
Experimental Diabetes Mellitus
Peripheral Arterial Disease
DNA-Binding Proteins
Nuclear Proteins
Research Design
Perfusion

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Biscetti, F., Straface, G., De Cristofaro, R., Lancellotti, S., Rizzo, P., Arena, V., ... Flex, A. (2010). High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes, 59(6), 1496-1505. https://doi.org/10.2337/db09-1507

High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. / Biscetti, Federico; Straface, Giuseppe; De Cristofaro, Raimondo; Lancellotti, Stefano; Rizzo, Paola; Arena, Vincenzo; Stigliano, Egidio; Pecorini, Giovanni; Egashira, Kensuke; De Angelis, Giulia; Ghirlanda, Giovanni; Flex, Andrea.

In: Diabetes, Vol. 59, No. 6, 01.06.2010, p. 1496-1505.

Research output: Contribution to journalArticle

Biscetti, F, Straface, G, De Cristofaro, R, Lancellotti, S, Rizzo, P, Arena, V, Stigliano, E, Pecorini, G, Egashira, K, De Angelis, G, Ghirlanda, G & Flex, A 2010, 'High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism', Diabetes, vol. 59, no. 6, pp. 1496-1505. https://doi.org/10.2337/db09-1507
Biscetti, Federico ; Straface, Giuseppe ; De Cristofaro, Raimondo ; Lancellotti, Stefano ; Rizzo, Paola ; Arena, Vincenzo ; Stigliano, Egidio ; Pecorini, Giovanni ; Egashira, Kensuke ; De Angelis, Giulia ; Ghirlanda, Giovanni ; Flex, Andrea. / High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. In: Diabetes. 2010 ; Vol. 59, No. 6. pp. 1496-1505.
@article{73b2e008c449490e8e8d6f734634003d,
title = "High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism",
abstract = "OBJECTIVE - High-mobility group box-1 (HMGB1) protein is a nuclear DNA-binding protein released from necrotic cells, inducing inflammatory responses and promoting tissue repair and angiogenesis. Diabetic human and mouse tissues contain lower levels of HMGB1 than their normoglycemic counterparts. Deficient angiogenesis after ischemia contributes to worse outcomes of peripheral arterial disease in patients with diabetes. To test the hypothesis that HMGB1 enhances ischemia-induced angiogenesis in diabetes, we administered HMGB1 protein in a mouse hind limb ischemia model using diabetic mice. RESEARCH DESIGN AND METHODS - After the induction of diabetes by streptozotocin, we studied ischemia-induced neovascularization in the ischemic hind limb of normoglycemic, diabetic, and HMGB1-treated diabetic mice. RESULTS - We found that the perfusion recovery was significantly attenuated in diabetic mice compared with normoglycemic control mice. Interestingly, HMGB1 protein expression was lower in the ischemic tissue of diabetic mice than in normoglycemic mice. Furthermore, we observed that HMGB1 administration restored the blood flow recovery and capillary density in the ischemic muscle of diabetic mice, that this process was associated with the increased expression of vascular endothelial growth factor (VEGF), and that HMGB1-induced angiogenesis was significantly reduced by inhibiting VEGF activity. CONCLUSIONS - The results of this study show that endogenous HMGB1 is crucial for ischemia-induced angiogenesis in diabetic mice and that HMGB1 protein administration enhances collateral blood flow in the ischemic hind limbs of diabetic mice through a VEGF-dependent mechanism.",
author = "Federico Biscetti and Giuseppe Straface and {De Cristofaro}, Raimondo and Stefano Lancellotti and Paola Rizzo and Vincenzo Arena and Egidio Stigliano and Giovanni Pecorini and Kensuke Egashira and {De Angelis}, Giulia and Giovanni Ghirlanda and Andrea Flex",
year = "2010",
month = "6",
day = "1",
doi = "10.2337/db09-1507",
language = "English",
volume = "59",
pages = "1496--1505",
journal = "Diabetes",
issn = "0012-1797",
publisher = "医学出版",
number = "6",

}

TY - JOUR

T1 - High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism

AU - Biscetti, Federico

AU - Straface, Giuseppe

AU - De Cristofaro, Raimondo

AU - Lancellotti, Stefano

AU - Rizzo, Paola

AU - Arena, Vincenzo

AU - Stigliano, Egidio

AU - Pecorini, Giovanni

AU - Egashira, Kensuke

AU - De Angelis, Giulia

AU - Ghirlanda, Giovanni

AU - Flex, Andrea

PY - 2010/6/1

Y1 - 2010/6/1

N2 - OBJECTIVE - High-mobility group box-1 (HMGB1) protein is a nuclear DNA-binding protein released from necrotic cells, inducing inflammatory responses and promoting tissue repair and angiogenesis. Diabetic human and mouse tissues contain lower levels of HMGB1 than their normoglycemic counterparts. Deficient angiogenesis after ischemia contributes to worse outcomes of peripheral arterial disease in patients with diabetes. To test the hypothesis that HMGB1 enhances ischemia-induced angiogenesis in diabetes, we administered HMGB1 protein in a mouse hind limb ischemia model using diabetic mice. RESEARCH DESIGN AND METHODS - After the induction of diabetes by streptozotocin, we studied ischemia-induced neovascularization in the ischemic hind limb of normoglycemic, diabetic, and HMGB1-treated diabetic mice. RESULTS - We found that the perfusion recovery was significantly attenuated in diabetic mice compared with normoglycemic control mice. Interestingly, HMGB1 protein expression was lower in the ischemic tissue of diabetic mice than in normoglycemic mice. Furthermore, we observed that HMGB1 administration restored the blood flow recovery and capillary density in the ischemic muscle of diabetic mice, that this process was associated with the increased expression of vascular endothelial growth factor (VEGF), and that HMGB1-induced angiogenesis was significantly reduced by inhibiting VEGF activity. CONCLUSIONS - The results of this study show that endogenous HMGB1 is crucial for ischemia-induced angiogenesis in diabetic mice and that HMGB1 protein administration enhances collateral blood flow in the ischemic hind limbs of diabetic mice through a VEGF-dependent mechanism.

AB - OBJECTIVE - High-mobility group box-1 (HMGB1) protein is a nuclear DNA-binding protein released from necrotic cells, inducing inflammatory responses and promoting tissue repair and angiogenesis. Diabetic human and mouse tissues contain lower levels of HMGB1 than their normoglycemic counterparts. Deficient angiogenesis after ischemia contributes to worse outcomes of peripheral arterial disease in patients with diabetes. To test the hypothesis that HMGB1 enhances ischemia-induced angiogenesis in diabetes, we administered HMGB1 protein in a mouse hind limb ischemia model using diabetic mice. RESEARCH DESIGN AND METHODS - After the induction of diabetes by streptozotocin, we studied ischemia-induced neovascularization in the ischemic hind limb of normoglycemic, diabetic, and HMGB1-treated diabetic mice. RESULTS - We found that the perfusion recovery was significantly attenuated in diabetic mice compared with normoglycemic control mice. Interestingly, HMGB1 protein expression was lower in the ischemic tissue of diabetic mice than in normoglycemic mice. Furthermore, we observed that HMGB1 administration restored the blood flow recovery and capillary density in the ischemic muscle of diabetic mice, that this process was associated with the increased expression of vascular endothelial growth factor (VEGF), and that HMGB1-induced angiogenesis was significantly reduced by inhibiting VEGF activity. CONCLUSIONS - The results of this study show that endogenous HMGB1 is crucial for ischemia-induced angiogenesis in diabetic mice and that HMGB1 protein administration enhances collateral blood flow in the ischemic hind limbs of diabetic mice through a VEGF-dependent mechanism.

UR - http://www.scopus.com/inward/record.url?scp=77953185946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953185946&partnerID=8YFLogxK

U2 - 10.2337/db09-1507

DO - 10.2337/db09-1507

M3 - Article

C2 - 20200317

AN - SCOPUS:77953185946

VL - 59

SP - 1496

EP - 1505

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -